术前NLR、PLR对评估结直肠息肉病理级别的临床价值分析
Clinical Value Analysis of Preoperative NLR and PLR in Evaluating the Pathological Grade of Colorectal Polyps
DOI: 10.12677/ACM.2022.121045, PDF,   
作者: 王占军:青岛大学医学院,山东 青岛;青岛大学附属医院消化内科,山东 青岛;韩志伟, 李芃萌, 宣碧碧:青岛大学医学院,山东 青岛;刘希双*:青岛大学附属医院消化内科,山东 青岛
关键词: 结直肠息肉中性粒细胞与淋巴细胞比值血小板与淋巴细胞比值瘤变癌变Colorectum Polyp Neutrophil to Lymphocyte Ratio Platelet to Lymphocyte Ratio Neoplasia Canceration
摘要: 目的:分析术前NLR、PLR与结直肠息肉病理级别的相关性,评估其对判断结直肠息肉癌变的临床价值。方法:回顾性分析青岛大学附属医院5525例瘤变或癌变的结直肠息肉患者,根据病理级别分为低级别瘤变组、高级别瘤变组、癌变组,分别3990例、451例和1084例,对各组NLR、PLR进行统计学分析。结果:不同病例组间NLR (H = 2243.238, P < 0.01)、PLR (H = 92007.94, P < 0.01)差异有统计学意义。各组NLR中位数随病理级别的升高依次增大(1.76、2.56、2.88),癌变组明显高于其他组;各组PLR中位数随病理级别的升高依次增大(119.83、155.65、176.02),癌变组明显高于其他组。Spearman秩相关分析显示不同病理级别和NLR、PLR间存在正相关性(P < 0.01)。在分层统计时,三组NLR均主要集中在0~4区段(85.4%、61.0%、59.6%);PLR主要集中在100~200区段(54.2%、50.6%、44.4%)。结论:NLR、PLR可以作为结直肠息肉病理级别升高的预测指标,对结直肠息肉发生高级别瘤变或癌变有一定的警示作用,但对高级别瘤变和癌变的鉴别诊断的价值、与息肉病理级别的计量对应关系有待进一步研究。
Abstract: Objective: To analyze the correlation between preoperative NLR, PLR and the pathological grade of colorectal polyp, and to evaluate their clinical value in the judgment of colorectal polyp canceration. Methods: A total of 5525 cases of colorectal polyps with neoplasia or canceration were retrospectively analyzed in The Affiliated Hospital of Qingdao University. According to pathological grade, they were divided into low grade tumor group, high grade tumor group and canceration group, 3990 cases, 451 cases and 1084 cases, respectively. NLR and PLR were statistically analyzed in each group. Results: There were significant differences in NLR (H = 2243.238, P < 0.01) and PLR (H = 92007.94, P < 0.01) among different case groups. The median NLR of each group increased with the increase of pathological grade (1.76, 2.56, 2.88), and the cancer group was significantly higher than that of other groups; the median PLR of each group increased with the increase of pathological grade (119.83, 155.65 and 176.02), and the cancer group was significantly higher than other groups. Spearman rank correlation analysis showed that there was a positive correlation between different pathological grades and NLR and PLR (P < 0.01). In stratified statistics, the NLR of the three groups was mainly concentrated in the 0~4 section (85.4%, 61.0%, 59.6%); PLR is mainly concentrated in 100~200 sections (54.2%, 50.6%, 44.4%). Conclusion: NLR and PLR can be used as predictors of pathological grade elevation of colorectal polyps, suggesting high-grade neoplasia or canceration of colorectal polyps to some extent. However, the value of differential diagnosis of high-grade neoplasia and canceration as well as the quantitative relationship between them and pathological grade of polyps need to be further studied.
文章引用:王占军, 韩志伟, 李芃萌, 宣碧碧, 刘希双. 术前NLR、PLR对评估结直肠息肉病理级别的临床价值分析[J]. 临床医学进展, 2022, 12(1): 297-304. https://doi.org/10.12677/ACM.2022.121045

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Miller, K.D., Nogueira, L., Mariotto, A.B., Rowland, J.H., Yabroff, K.R., Alfano, C.M., Jemal, A., Kramer, J.L. and Siegel, R.L. (2019) Cancer Treatment and Survivorship Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 363-385. [Google Scholar] [CrossRef] [PubMed]
[3] Wu, Y., Chen, Y., Yang, X., Chen, L. and Yang, Y. (2016) Neutrophil-to-Lymphocyte Ratio (Nlr) and Platelet-to-Lymphocyte Ratio (Plr) Were Associated with Disease Activity in Patients with Systemic Lupus Erythematosus. International Immunopharmacology, 36, 94-99. [Google Scholar] [CrossRef] [PubMed]
[4] Tahto, E., Jadric, R., Pojskic, L. and Kicic, E. (2017) Neutrophil-to-Lymphocyte Ratio and Its Relation with Markers of Inflammation and Myocardial Necrosis in Patients with Acute Coronary Syndrome. Medical Archives, 71, 312-315. [Google Scholar] [CrossRef] [PubMed]
[5] Stojkovic Lalosevic, M., Pavlovic Markovic, A., Stankovic, S., Stojkovic, M., Dimitrijevic, I., Radoman Vujacic, I., Lalic, D., Milovanovic, T., Dumic, I. and Krivokapic, Z. (2019) Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (Nlr), Platelet-to-Lymphocyte Ratio (Plr), and Mean Platelet Volume (Mpv) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer. Disease Markers, 2019, Article ID: 6036979. [Google Scholar] [CrossRef] [PubMed]
[6] Greten, F.R. and Grivennikov, S.I. (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity, 51, 27-41. [Google Scholar] [CrossRef] [PubMed]
[7] O’Callaghan, D.S., O’Donnell, D., O’Connell, F. and O’Byrne, K.J. (2010) The Role of Inflammation in the Pathogenesis of Non-Small Cell Lung Cancer. Journal of Thoracic Oncology, 5, 2024-2036. [Google Scholar] [CrossRef
[8] Aggarwal, B.B., Vijayalekshmi, R.V. and Sung, B. (2009) Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe. Clinical Cancer Research, 15, 425-430. [Google Scholar] [CrossRef
[9] Kadariya, Y., Menges, C.W., Talarchek, J., Cai, K.Q., Klein-Szanto, A.J., Pietrofesa, R.A., Christofidou-Solomidou, M., Cheung, M., Mossman, B.T., Shukla, A. and Testa, J.R. (2016) Inflammation-Related Il1β/Il1r Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prevention Research, 9, 406-414. [Google Scholar] [CrossRef
[10] Takahashi, H., Ogata, H., Nishigaki, R., Broide, D.H. and Karin, M. (2010) Tobacco Smoke Promotes Lung Tumorigenesis by Triggering Ikkbeta- and Jnk1-Dependent Inflammation. Cancer Cell, 17, 89-97. [Google Scholar] [CrossRef] [PubMed]
[11] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[12] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef
[13] Petrie, H.T., Klassen, L.W. and Kay, H.D. (1985) Inhibition of Human Cytotoxic T Lymphocyte Activity in Vitro by Autologous Peripheral Blood Granulocytes. The Journal of Immunology, 134, 230-234.
[14] el-Hag, A. and Clark, R.A. (1987) Immunosuppression by Activated Human Neutrophils. Dependence on the Myeloperoxidase System. The Journal of Immunology, 139, 2406-2413.
[15] Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J.P., Hitre, E., de Azambuja, E., Quinaux, E., Di Leo, A., Michiels, S., Piccart, M.J. and Sotiriou, C. (2013) Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin with Doxorubicin-Based Chemotherapy: Big 02-98. Clinical Oncology, 31, 860-867. [Google Scholar] [CrossRef
[16] Gooden, M.J., de Bock, G.H., Leffers, N., Daemen, T. and Nijman, H.W. (2011) The Prognostic Influence of Tumour-Infiltrating Lymphocytes in Cancer: A Systematic Review with Meta-Analysis. British Journal of Cancer, 105, 93-103. [Google Scholar] [CrossRef] [PubMed]
[17] Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B.M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., von Törne, C., Weichert, W., Engels, K., Solbach, C., Schrader, I., Dietel, M. and von Minckwitz, G. (2010) Tumor-Associated Lymphocytes as an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Oncology, 28, 105-113. [Google Scholar] [CrossRef
[18] Kawamura, Y., Takeshita, S., Kanai, T., Yoshida, Y. and Nonoyama, S. (2016) The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease. The Journal of Pediatrics, 178, 281-284.e281. [Google Scholar] [CrossRef] [PubMed]
[19] Guthrie, G.J., Charles, K.A., Roxburgh, C.S., Horgan, P.G., McMillan, D.C. and Clarke, S.J. (2013) The Systemic Inflammation-Based Neutrophil-Lymphocyte Ratio: Experience in Patients with Cancer. Critical Reviews in Oncology/Hematology, 88, 218-230. [Google Scholar] [CrossRef] [PubMed]
[20] Templeton, A.J., McNamara, M.G., Seruga, B., Vera-Badillo, F.E., Aneja, P., Ocana, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., Tannock, I.F. and Amir, E. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
[21] Kalyoncuoglu, M., Biter, H., Ozturk, S., Belen, E. and Can, M.M. (2020) Predictive Accuracy of Lymphocyte-to-Monocyte Ratio and Monocyte-to-High-Density-Lipoprotein-Cholesterol Ratio in Determining the Slow Flow/No-Reflow Phenomenon in Patients with Non-St-Elevated Myocardial Infarction. Coronary Artery Disease, 31, 518-526. [Google Scholar] [CrossRef
[22] Song, S.Y., Zhao, X.X., Rajah, G., Hua, C., Kang, R.J., Han, Y.P., Ding, Y.C. and Meng, R. (2019) Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients with Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis. Frontiers in Neurology, 10, Article No. 1032. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, L., Song, Q., Wang, C., Wu, S., Deng, L., Li, Y., Zheng, L. and Liu, M. (2019) Neutrophil to Lymphocyte Ratio Predicts Poor Outcomes after Acute Ischemic Stroke: A Cohort Study and Systematic Review. Neurological Sciences, 406, Article ID: 116445. [Google Scholar] [CrossRef] [PubMed]
[24] Templeton, A.J., Ace, O., McNamara, M.G., Al-Mubarak, M., Vera-Badillo, F.E., Hermanns, T., Seruga, B., Ocaña, A., Tannock, I.F. and Amir, E. (2014) Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Cancer Epidemiology, Biomarkers & Prevention, 23, 1204-1212. [Google Scholar] [CrossRef
[25] Yodying, H., Matsuda, A., Miyashita, M., Matsumoto, S., Sakurazawa, N., Yamada, M. and Uchida, E. (2016) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology, 23, 646-654. [Google Scholar] [CrossRef] [PubMed]
[26] Zhao, Q.T., Yuan, Z., Zhang, H., Zhang, X.P., Wang, H.E., Wang, Z.K. and Duan, G.C. (2016) Prognostic Role of Platelet to Lymphocyte Ratio in Non-Small Cell Lung Cancers: A Meta-Analysis Including 3,720 Patients. International Journal of Cancer, 139, 164-170. [Google Scholar] [CrossRef] [PubMed]
[27] Lu, C., Gao, P., Yang, Y., Chen, X., Wang, L., Yu, D., Song, Y., Xu, Q. and Wang, Z. (2017) Prognostic Evaluation of Platelet to Lymphocyte Ratio in Patients with Colorectal Cancer. Oncotarget, 8, 86287-86295. [Google Scholar] [CrossRef] [PubMed]
[28] Hirahara, T., Arigami, T., Yanagita, S., Matsushita, D., Uchikado, Y., Kita, Y., Mori, S., Sasaki, K., Omoto, I., Kurahara, H., Maemura, K., Okubo, K., Uenosono, Y., Ishigami, S. and Natsugoe, S. (2019) Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predicts Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer. BMC Cancer, 19, Article No. 672. [Google Scholar] [CrossRef] [PubMed]
[29] 程迎迎, 张洁, 李鹏飞, 等. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值对溃疡性结肠炎的诊断价值[J]. 国际检验医学杂志, 2021, 42(2): 137-141.
[30] Roos, V.H., Mangas-Sanjuan, C., Rodriguez-Girondo, M., Medina-Prado, L., Steyerberg, E.W., Bossuyt, P.M.M., Dekker, E., Jover, R. and van Leerdam, M.E. (2019) Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 17, 2657-2667.e2659. [Google Scholar] [CrossRef] [PubMed]
[31] Lutgens, M.W., van Oijen, M.G., van der Heijden, G.J., Vleggaar, F.P., Siersema, P.D. and Oldenburg, B. (2013) Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-Analysis of Population-Based Cohort Studies. Inflammatory Bowel Diseases, 19, 789-799. [Google Scholar] [CrossRef
[32] Händel, M.N., Rohde, J.F., Jacobsen, R., Nielsen, S.M., Christensen, R., Alexander, D.D., Frederiksen, P. and Heitmann, B.L. (2020) Processed Meat Intake and Incidence of Colorectal Cancer: A Systematic Review and Meta-Analysis of Prospective Observational Studies. European Journal of Clinical Nutrition, 74, 1132-1148. [Google Scholar] [CrossRef] [PubMed]
[33] Pan, X.F., He, M., Yu, C., Lv, J., Guo, Y., Bian, Z., Yang, L., Chen, Y., Wu, T., Chen, Z., Pan, A. and Li, L. (2018) Type 2 Diabetes and Risk of Incident Cancer in China: A Prospective Study among 0.5 Million Chinese Adults. The American Journal of Epidemiology, 187, 1380-1391. [Google Scholar] [CrossRef] [PubMed]
[34] Fang, X., Wei, J., He, X., Lian, J., Han, D., An, P., Zhou, T., Liu, S., Wang, F. and Min, J. (2018) Quantitative Association between Body Mass Index and the Risk of Cancer: A Global Meta-Analysis of Prospective Cohort Studies. International Journal of Cancer, 143, 1595-1603. [Google Scholar] [CrossRef] [PubMed]
[35] Mizota, Y., Kanemitsu, Y., Tsukamoto, S., Shida, D., Ochiai, H. and Yamamoto, S. (2018) ROK Study-C (Rainbow of Kibou Study-Colorectum): A Colorectal Cancer Survivor Cohort Study on Food, Nutrition, Physical Activity, Psychosocial Factors and Its Influences on Colorectal Cancer Recurrence, Survival and Quality of Life in Japan. BMC Cancer, 18, Article No. 953. [Google Scholar] [CrossRef] [PubMed]
[36] Ma, N., Tian, Y., Wu, Y. and Ma, X. (2017) Contributions of the Interaction between Dietary Protein and Gut Microbiota to Intestinal Health. Current Protein & Peptide Science, 18, 795-808. [Google Scholar] [CrossRef] [PubMed]
[37] Hong, S.N., Lee, T.Y. and Yun, S.C. (2015) The Risk of Colorectal Neoplasia in Patients with Gallbladder Diseases. Journal of Korean Medical Science, 30, 1288-1294. [Google Scholar] [CrossRef] [PubMed]